RichardAPrestonMD

Nephrology • Miami, FL

Physician

Join to view full profile

Dr. Preston is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Preston's full profile

Already have an account?

Office
1611 NW 12th Ave
# M851
Miami, FL 33136
Phone+1 305-243-4664

Fax+1 305-243-8470

Education & Training

University of Miami/Jackson Health SystemFellowship, Nephrology, 1986 - 1988
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1979 - 1982
University of California San Diego School of MedicineClass of 1979

Certifications & Licensure

FL State Medical License 1981 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Clinical Trials

Nebivolol Versus Metoprolol: Sodium Sensitivity Start of enrollment: 2010 Dec 01
Completed
Phase 4
Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment Start of enrollment: 2014 Sep 01
Completed
Phase 1
A Phase 1 Study to Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Impairment Start of enrollment: 2020 Jul 09
Completed
Phase 1
Pharmacokinetics of XNW4107 in Subjects With Various Degrees of Renal Function Start of enrollment: 2021 Feb 25
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Effect of Hepatic Impairment on Trilaciclib Pharmacokinetics.
Chao Li, Richard A Preston, Emily Dumas, Andrew Beelen, Thomas C Marbury
Journal of Clinical Pharmacology. 2024-08-01
1 citations
Pharmacokinetics and Safety of Multiple-Dose Alpelisib in Participants with Moderate or Severe Hepatic Impairment: A Phase 1, Open-Label, Parallel Group Study.
Thomas Marbury, Mona El-Hashimy, Lars Blumenstein, Franck Letellier, Tirtha Sengupta
Journal of Cancer. 2023-01-01
41 citations
Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID-19, in Subjects With Renal Impairment.
Sima S Toussi, Joel Michael Neutel, Jesus Navarro, Richard Alfred Preston, Haihong Shi
Clinical Pharmacology and Therapeutics. 2022-10-01

Press Mentions

COVID Lockdowns Were a Giant Experiment. It Was a FailureNovember 1st, 2023